J&J publish series of CCR2 antagonists « GPCR News

Tags

5-HT1A 5-HT2 5-HT2A 5-HT3 5-HT4 5-ht6 5HT1A 5HT1D 5HT2 5HT2A 5HT3 5HT4 5ht6 agonist Angiotensin II AT1 antagonist Astrazeneca Beta 2 adrenoceptor Cannabinoid CB1 Daiichi-Sankyo Dopamine Dopamine D2 Fentanyl ghrelin GlaxoSmithkline GLP-1 gpcr GSK Histamine H1 Licensing Lilly Merck Muscarinic Opioid Opioid mu phase I phase II phase III Preclinical regulatory Research Sanofi-Aventis TRPV1 Vanilloid
October 2008

M T W T F S S

« Sep Nov »

1 2 3 4 5

6 7 8 9 10 11 12

13 14 15 16 17 18 19

20 21 22 23 24 25 26

27 28 29 30 31

J&J publish series of CCR2 antagonists

Posted on October 24, 2008 by crimsoncanary

J&J have published a series of 7-Azaindole Piperidine CCR2 Antagonists

Filed under: Uncategorized | Tagged: antagonist, CCR-2, CCR2, J&J, Johnson and Johnson

« Daiichi Sankyo and Lilly continue talks with FDA re Prasugrel NDA Pfizer publish series of Alpha1A Adrenoceptor Partial Agonists »